Original Paper Published: 12 October 2000 Estrogen receptor β acts as a dominant regulator of estrogen signaling Katarina Pettersson, Franck Delaunay & Jan-Åke Gustafsson Oncogene 19, 4970 ...

Researchers at the NYU Pain Research Center have found a new receptor for nerve growth factor that plays an important role in pain signaling, even though it does not signal on its own, according ...

About 40% of patients treated with aromatase inhibitors develop mutations in the estrogen receptor 1 gene called ESR1 mutations, a sign of early drug resistance. Camizestrant and similar drugs called ...

Additionally, while the estrogen signaling pathway was found to be overexpressed, there were no significant changes in estrogen hormone receptors.